333 related articles for article (PubMed ID: 29477941)
21. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
22. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
Shafique S; Bona R; Kaplan AA
Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
[TBL] [Abstract][Full Text] [Related]
24. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
25. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
26. The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.
Nguyen R; Jeha S; Zhou Y; Cao X; Cheng C; Bhojwani D; Campbell P; Howard SC; Rubnitz J; Ribeiro RC; Sandlund JT; Gruber T; Inaba H; Pui CH; Metzger ML
Pediatr Blood Cancer; 2016 Sep; 63(9):1546-51. PubMed ID: 27187265
[TBL] [Abstract][Full Text] [Related]
27. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis.
Zhao J; Bewersdorf JP; Jaszczur S; Kowalski A; Perreault S; Schiffer M; Gore S; Podoltsev N; Prebet T; Shallis R; Zeidan AM
Leuk Lymphoma; 2021 May; 62(5):1195-1202. PubMed ID: 33325761
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Christakopoulos GE; Walker KN; Smith J; Takemoto CM; Zheng Y; Pui CH; Ribeiro RC; Wang L; Pounds SB; Rubnitz JE; Inaba H
Cancer; 2023 Jun; 129(12):1873-1884. PubMed ID: 36943896
[TBL] [Abstract][Full Text] [Related]
29. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
30. Leukapheresis in childhood acute leukemias: single-center experience.
Yilmaz D; Karapinar B; Karadaş N; Duyu M; Yazici P; Ay Y; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 May; 31(4):318-26. PubMed ID: 23988130
[TBL] [Abstract][Full Text] [Related]
31. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis.
Göçer M; Kurtoğlu E
Ther Apher Dial; 2021 Oct; 25(5):697-703. PubMed ID: 33686785
[TBL] [Abstract][Full Text] [Related]
32. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic leukapheresis in a tertiary care hospital: A case series.
Makroo RN; Kakkar B; Chowdhry M; Agrawal S; Seth S; Thakur UK
Asian J Transfus Sci; 2017; 11(1):65-68. PubMed ID: 28316445
[TBL] [Abstract][Full Text] [Related]
35. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome.
Blum W; Porcu P
Semin Thromb Hemost; 2007 Jun; 33(4):350-4. PubMed ID: 17525892
[TBL] [Abstract][Full Text] [Related]
37. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea.
Hwang WL; Gau JP; Chen MC; Young JH
Am J Hematol; 1993 Aug; 43(4):323-4. PubMed ID: 8372818
[No Abstract] [Full Text] [Related]
38. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
39. [Leukostasis and tumor lysis: important complications of hyperleukocytosis].
Schellongowski P; Staudinger T
Internist (Berl); 2013 Sep; 54(9):1051-60. PubMed ID: 23943008
[TBL] [Abstract][Full Text] [Related]
40. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]